ArticlePharmaceuticals (Basel, Switzerland)2025

A Bioorthogonal TCO-Tetrazine-Based Pretargeted PET/NIRF Platform Enabling High-Contrast Tumor Imaging.

Mingxing Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.